BPC-157 + TB-500 20 mg Blend

Healing & recovery Research compound (not approved for human use)

Tissue-repair research blend (BPC-157 + TB-500) · also known as BPC-157/TB-500 blend

For reference only — not medical advice. Figures are commonly reported values compiled from published sources and may be wrong or out of date. Many compounds listed are not approved for human use. Talk to a licensed clinician before using any compound.

This blend combines BPC-157 and TB-500 in a single vial (20 mg by default, with a 10 mg size also listed), a common pairing in recovery-oriented research because the two peptides are studied for complementary roles in tissue-repair research.

Commonly reported dosing (20 mg vial)

Reconstituted with 3 mL → 6.667 mg/mL.

Also sold in 10 mg vials.

Phase	Dose	Volume	U-100 units
Starting Weeks 1-2, total blend	500 mcg	0.075 mL	7.5
Standard Weeks 3-4, total blend; the reference chart lists about 666 mcg (10 units at this concentration), rounded here.	650 mcg	0.098 mL	9.8
Higher Weeks 5-8, total blend	1 mg	0.15 mL	15

Each 500 mcg draw contains 250 mcg BPC-157 + 250 mcg TB-500.

Frequency: Once daily, subcutaneous · Half-life: Mixed (see individual peptides)

Open in calculator

Commonly reported reconstitution steps

Vials are usually brought to room temperature (about 15-20 minutes) first.
3 mL of bacteriostatic water is added slowly down the inside wall of the 20 mg vial.
The vial is swirled gently until clear, not shaken.
This gives 6.67 mg/mL. Mixed vials are typically labeled with the date and refrigerated.

Storage

Before mixing: Sealed vials are commonly stored refrigerated (2-8 °C) and protected from light, or frozen for long-term storage.

After mixing: Reconstituted solution is commonly kept refrigerated (2-8 °C), protected from light, and not frozen.

Commonly used within 28 days of mixing.

How it works

BPC-157 is associated with angiogenesis and growth-factor signaling, while TB-500 (a thymosin beta-4 fragment) is associated with actin regulation and cell migration. Together they are studied as a combined approach in tissue-repair research.

Researched for

Studied as a combined BPC-157 and TB-500 protocol.
Investigated in connective-tissue and soft-tissue repair research.

Notes

Because it is a blend, the per-dose amount covers both peptides together.
The 10 mg size is commonly listed with 5 mg of each peptide; the component split shown here is for the 20 mg default and scales proportionally.
Reconstituted solution is commonly refrigerated.